Cargando…
Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists
BACKGROUND: Oral albuterol has worse efficacy and side effects compared with inhaled albuterol, and thus its use has been discouraged for decades. Drug inclusion or exclusion on formularies have been associated with reductions in low-value care. This study examines dispensing of oral albuterol and i...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044602/ https://www.ncbi.nlm.nih.gov/pubmed/35473608 http://dx.doi.org/10.1186/s12913-022-07955-x |